INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (BIOT) Named Rep for IN01 in Japan and China

BIOT was appointed non-exclusive authorized representative by CelSiege Biosciences to introduce and develop IN01, a clinical-stage EGF-targeting cancer immunotherapy, in Japan and China. Any transactions remain subject to separate negotiations and agreements.Material DetailsContext by AI AnalystThi…